BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31269779)

  • 1. STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice.
    Boutillon F; Pigat N; Sala LS; Reyes-Gomez E; Moriggl R; Guidotti JE; Goffin V
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31269779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis.
    Yang X; Meyer K; Friedl A
    J Biol Chem; 2013 Jul; 288(29):21184-21196. PubMed ID: 23729680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
    Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
    Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial defect in prostates of Stat5a-null mice.
    Nevalainen MT; Ahonen TJ; Yamashita H; Chandrashekar V; Bartke A; Grimley PM; Robinson GW; Hennighausen L; Rui H
    Lab Invest; 2000 Jul; 80(7):993-1006. PubMed ID: 10908145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors.
    Rouet V; Bogorad RL; Kayser C; Kessal K; Genestie C; Bardier A; Grattan DR; Kelder B; Kopchick JJ; Kelly PA; Goffin V
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15199-204. PubMed ID: 20699217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin-induced prostate tumorigenesis.
    Sackmann-Sala L; Goffin V
    Adv Exp Med Biol; 2015; 846():221-42. PubMed ID: 25472541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro.
    Ahonen TJ; Härkönen PL; Rui H; Nevalainen MT
    Endocrinology; 2002 Jan; 143(1):228-38. PubMed ID: 11751614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
    Goffin V
    Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and murine prostate basal/stem cells are not direct targets of prolactin.
    Sackmann-Sala L; Angelergues A; Boutillon F; d'Acremont B; Maidenberg M; Oudard S; Goffin V
    Gen Comp Endocrinol; 2015 Sep; 220():133-42. PubMed ID: 25888939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
    Nevalainen MT; Xie J; Bubendorf L; Wagner KU; Rui H
    Mol Endocrinol; 2002 May; 16(5):1108-24. PubMed ID: 11981045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells.
    Buser AC; Gass-Handel EK; Wyszomierski SL; Doppler W; Leonhardt SA; Schaack J; Rosen JM; Watkin H; Anderson SM; Edwards DP
    Mol Endocrinol; 2007 Jan; 21(1):106-25. PubMed ID: 16973758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin-induced prostate tumorigenesis links sustained Stat5 signaling with the amplification of basal/stem cells and emergence of putative luminal progenitors.
    Sackmann-Sala L; Chiche A; Mosquera-Garrote N; Boutillon F; Cordier C; Pourmir I; Pascual-Mathey L; Kessal K; Pigat N; Camparo P; Goffin V
    Am J Pathol; 2014 Nov; 184(11):3105-19. PubMed ID: 25193592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.
    Kindblom J; Dillner K; Sahlin L; Robertson F; Ormandy C; Törnell J; Wennbo H
    Endocrinology; 2003 Jun; 144(6):2269-78. PubMed ID: 12746285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate.
    Dillner K; Kindblom J; Flores-Morales A; Shao R; Törnell J; Norstedt G; Wennbo H
    Endocrinology; 2003 Nov; 144(11):4955-66. PubMed ID: 12960074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective coupling of STAT factors to the mouse prolactin receptor.
    Mayr S; Welte T; Windegger M; Lechner J; May P; Heinrich PC; Horn F; Doppler W
    Eur J Biochem; 1998 Dec; 258(2):784-93. PubMed ID: 9874248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade.
    Li H; Ahonen TJ; Alanen K; Xie J; LeBaron MJ; Pretlow TG; Ealley EL; Zhang Y; Nurmi M; Singh B; Martikainen PM; Nevalainen MT
    Cancer Res; 2004 Jul; 64(14):4774-82. PubMed ID: 15256446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of castration-induced prostate stroma regression is reduced in a mouse model of benign prostatic hyperplasia.
    Zhang R; Singh S; Pan C; Xu B; Kindblom J; Eng KH; Krolewski JJ; Nastiuk KL
    Am J Clin Exp Urol; 2023; 11(1):12-26. PubMed ID: 36923722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Plasticity in a Mouse Model of Benign Prostate Hyperplasia Drives Amplification of Androgen-Independent Epithelial Cell Populations Sensitive to Antioxidant Therapy.
    Dos Santos L; Carbone F; Pacreau E; Diarra S; Luka M; Pigat N; Baures M; Navarro E; Anract J; Barry Delongchamps N; Cagnard N; Bost F; Nemazanyy I; Petitjean O; Hamaï A; Ménager M; Palea S; Guidotti JE; Goffin V
    Am J Pathol; 2024 Jan; 194(1):30-51. PubMed ID: 37827216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
    Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
    Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.